Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Quick Reference

  • Code definition: CPT 95165 covers the physician's professional service of supervising the formulation and dispensing of patient-specific antigen multi-dose vials for subcutaneous allergen immunotherapy; it does not include injection administration or allergy testing.
  • Key billing rule: Units equal the number of individual injection doses contained in the vial or prescription, not the number of vials. Bill the exact dose count documented in the antigen prescription.
  • Modifier essentials: Modifier 25 applies to any separately identifiable E/M service on the same date; append it to the E/M code, not to 95165. Modifier 59 may be needed when a payer incorrectly bundles 95165 with 95115 or 95117. Modifiers 26 and TC do not apply (PC/TC indicator = 0) [3].
  • Documentation must-have: A written antigen prescription specifying allergens, dilution/concentration protocol, and total dose count; the unit count billed must reconcile to this record.
  • Top confusion point: CPT 95165 applies to multi-dose vials billed per dose; CPT 95144 applies to single-dose vials billed per vial. Applying the wrong code when vial type differs is the most common systematic billing error in allergy practices.
  • Payer alert: In hospital outpatient settings, 95165 carries APC Status STV-Packaged and is not separately reimbursed on the facility claim; the professional component remains separately billable under the physician's NPI [3].
  • MUE: CMS NCCI limits 95165 to 30 units per patient per day; claims exceeding this cap deny automatically [1].

When to Use This Code

CPT 95165 applies when a supervising allergist or qualified physician oversees the preparation and dispensing of multi-dose antigen vials for inhalant allergens (pollens, mold, dust mite, animal dander) or other non-Hymenoptera allergens, and those vials are not administered by the prescribing physician during the same encounter. The standard workflow: the allergist formulates a patient-specific multi-dose vial based on prior allergy testing results, administers the first injection (billed separately as 95115), and provides the remaining vials to the patient or an administering physician for subsequent injections.

The code applies across both the build-up and maintenance phases of subcutaneous immunotherapy. The critical scope boundary is vial type: 95165 is exclusively for multi-dose vials. If the prescribing physician prepares single-dose vials instead, the appropriate code is 95144 regardless of allergen type.

Setting determines payment. POS 11 (office) is standard for separately payable professional billing. POS 22 (outpatient hospital) triggers OPPS packaging rules, and the facility claim will not generate separate payment for 95165 because its APC status is STV-Packaged. The professional claim under the physician's NPI with POS 22 remains separately billable [3].


Code Differentiation Table

Code Description When to Use Instead
95165 Antigen supervision, single or multiple antigens, multi-dose vials; billed per dose Primary use: inhalant or non-venom allergens prepared in multi-dose format
95144 Antigen supervision, single-dose vials; billed per vial When preparation produces individual single-dose vials rather than a multi-dose vial
95145 Antigen supervision, single stinging insect venom Hymenoptera venom immunotherapy for one venom species; billed per prescription, not per dose
95146 Antigen supervision, two stinging insect venoms Two Hymenoptera venom species prepared in the same prescription
95120 Allergen immunotherapy at prescribing physician's office, extract included; single injection When the prescribing physician administers the injection at their own office during the same encounter as extract provision; replaces the 95165 plus 95115 combination
95125 Same as 95120 but two or more injections Same as above when the patient receives two or more injections at the prescribing physician's office
95115 Allergen immunotherapy injection, no provision of extract; single injection The injection administration service, distinct from antigen preparation; pairs with 95165 and does not replace it

The most consequential distinction in allergy billing is 95120/95125 versus 95165 paired with 95115/95117. Use 95120 or 95125 only when the prescribing physician performs the injection at their own office during the same encounter as the extract provision. Use 95165 alongside 95115 or 95117 when antigen preparation and injection are distinct services, whether at different sites or billed separately by the prescribing physician when both are independently documented [6].

flowchart TD
    A[Antigen preparation service] --> B{Hymenoptera venom?}
    B -->|Yes| C[95145 to 95149 by venom count]
    B -->|No| D{Vial type?}
    D -->|Single-dose vials| E[95144 per vial]
    D -->|Multi-dose vial| F{Injection by prescribing physician same encounter at same office?}
    F -->|Yes| G[95120 or 95125]
    F -->|No| H[95165 per dose]

Billing and Modifier Rules

Units: Each unit of 95165 represents one injection-equivalent dose. A vial containing 20 doses is billed as 95165 × 20 units. The CPT instruction "specify number of doses" is reflected in the unit count on the claim; do not submit one unit per vial [6].

MUE cap: CMS NCCI MUE = 30 units per day [1]. If a prescription legitimately contains more than 30 doses, bill across the actual preparation dates rather than artificially concentrating multiple dates into one.

Modifier 25: Apply to the separately identifiable E/M code on the same date, not to 95165. Documentation must establish that the E/M service addressed a problem distinct from routine antigen supervision.

Modifier 59: Apply to 95115 or 95117 when billed on the same date as 95165 and the payer incorrectly bundles them. Preparation and injection are distinct services; XU (unusual non-overlapping service) is an alternative X-modifier supported by claims data for this pairing.

Modifier 76: Use when the same physician repeats the antigen preparation service on the same date, such as preparing separate vials for two distinct allergen protocols in a single encounter.

Modifiers 26/TC: Do not apply; PC/TC indicator = 0 [3].

Modifier 51: No payment adjustment for multiple procedures applies; indicator = 0.

NCCI bundling: CPT 95165 and 95120/95125 are mutually exclusive for the same allergens on the same date; billing both is duplicate billing. CPT 95165 and 95115/95117 are not automatically bundled and may legitimately appear together when both services are genuinely performed and documented [2].


Documentation Essentials

The written antigen prescription is the primary audit anchor. It must specify the allergens included, the dilution series and concentration for each antigen, and the total number of doses prepared. The unit count on the claim must reconcile exactly to the dose count in this document.

Supporting the antigen prescription, the record must contain allergy workup documentation (skin test results or specific IgE laboratory reports) that justifies antigen selection. Auditors expect a logical connection between documented sensitivities and the antigens formulated [4].

Physician oversight must be documentable. The physician need not physically compound the vials, but the record should reflect review of the formulation protocol and medical decision-making regarding allergen selection and dosing. Incident-to billing requires the physician to be present in the office suite during preparation by non-physician staff.

Audit red flags specific to 95165:

  • Units claimed do not match dose count in the antigen prescription
  • No allergy testing documentation predating the antigen preparation
  • CPT 95165 billed alongside 95120 or 95125 on the same date
  • Units exceeding the MUE of 30 without a split preparation date rationale

Medicare, Commercial and Medicaid Payer Rules

Medicare

Allergen immunotherapy is a covered Part B benefit following diagnostic evaluation [5]. CMS requires allergy testing results on file before antigen preparation is medically necessary. Multiple MACs maintain LCDs addressing allergen immunotherapy; WPS LCD L36728 (Allergy Testing and Immunotherapy) documents covered diagnoses, medical necessity criteria, and documentation requirements [4]. Verify the applicable jurisdiction's LCD, as Noridian, NGS, CGS, Palmetto, and Novitas may maintain parallel policies with differing requirements.

The MUE of 30 units per day is an administrative hard limit under NCCI [1]. Claims exceeding this limit deny without appeal opportunity unless billing reflects actual split preparation dates.

In hospital outpatient settings, POS 22 triggers OPPS packaging: the facility claim will not generate separate payment for 95165 (APC Status STV-Packaged). The professional claim under the physician's NPI at POS 22 remains separately billable at non-facility professional rates [3].

Commercial Payers

Commercial policies generally follow Medicare coverage logic for allergen immunotherapy but may impose prior authorization requirements for the initial antigen prescription or annual dose thresholds. Some payers apply automated edits that limit units per claim line; verify payer-specific policies before submitting claims with unit counts near the MUE cap. Documentation requirements for Modifier 59 when 95165 and injection codes appear together may be stricter than Medicare standards; maintain clear documentation establishing preparation and injection as distinct, separately performed services.


Common Denials and Prevention

Incorrect unit count (doses counted as vials) Billing one unit per vial rather than per dose is the most common claim error for 95165 and produces systematic underbilling. Prevention: build a workflow that extracts the dose count directly from the antigen prescription before claim submission and verifies it against the unit billed.

Duplicate billing with 95120 or 95125 When both 95165 and 95120 appear on the same claim, payers deny or reduce one as duplicate because 95120 already includes extract provision. Prevention: confirm whether the prescribing physician administered the injection at their own office during the same encounter. If so, use 95120 or 95125 exclusively.

MUE exceeded Claims with more than 30 units of 95165 on a single date of service deny automatically under NCCI [1]. Prevention: if a prescription contains more than 30 doses, verify whether preparation occurred across multiple dates and bill on those actual dates. Artificially splitting a single-day preparation across dates to circumvent the MUE creates false claims risk.

Missing medical necessity diagnosis Claims without an ICD-10-CM diagnosis supporting allergic disease deny for medical necessity. Prevention: ensure at least one allergic condition code appears on every 95165 claim. Common supporting diagnoses include J30.1 (allergic rhinitis due to pollen), J30.89 (other allergic rhinitis), J30.81 (allergic rhinitis due to animal hair and dander), and J45.20 through J45.51 for allergic asthma.

Incorrect Modifier 26 or TC application Some coders apply Modifier 26 to 95165 to isolate a professional component. The PC/TC indicator for this code is 0, meaning the concept does not apply [3]. Modifier 26 on 95165 may not trigger an edit but produces an incorrect claim that invites audit scrutiny.


Coding Scenarios

Scenario 1: An allergist formulates a 20-dose maintenance multi-dose vial for a patient with perennial allergic rhinitis due to dust mite and cat dander. No injection is given today; the patient takes the vial to their primary care physician for ongoing subcutaneous immunotherapy.

Correct coding: 95165 × 20 units; diagnoses J30.89, J30.81

Why: 95165 captures multi-dose vial preparation billed per dose. No injection code is submitted because the allergist did not administer an injection. 95120 does not apply because the injection will occur at a different provider's office.

Scenario 2: The same allergist prepares a new 15-dose build-up vial and administers a single injection from that vial at the same visit.

Correct coding: 95165 × 15 units + 95115 × 1 unit (Modifier 59 on 95115 if payer bundles); diagnosis J30.89

Why: Preparation and injection are distinct services when separately documented. CPT 95120 is an all-in-one code that is appropriate only when the prescribing physician's office provides both extract and injection as the primary encounter service; separate billing of 95165 and 95115 is appropriate when both services are independently documented.

Scenario 3: An allergist in a hospital-based allergy clinic prepares a 20-dose antigen vial for a Medicare patient with mild intermittent allergic asthma.

Correct coding (professional claim): 95165 × 20 units, POS 22; diagnosis J45.20

Correct coding (facility claim): 95165 is STV-Packaged; no separate facility payment is generated.

Why: The professional physician claim is separately payable regardless of the OPPS setting. The facility is reimbursed through the visit APC; 95165 does not generate a separate facility line item payment.

Scenario 4: A coder receives a claim for antigen preparation for a patient with bee sting allergy. The vial contains mixed vespid venom covering yellow jacket and white-faced hornet (two separate venoms).

Correct coding: 95146 × 1; diagnoses Z91.030, Z91.038

Why: Hymenoptera venom immunotherapy is reported with 95145 through 95149 based on the number of venom species, not with 95165. CPT 95146 covers two stinging insect venoms prepared in the same prescription. Using 95165 for venom immunotherapy is incorrect code selection.


Related Codes

  • 95115: Allergen immunotherapy injection, single, no extract provided; the injection administration code paired with 95165 when the prescribing physician administers the first injection
  • 95117: Allergen immunotherapy injection, two or more, no extract provided; use instead of 95115 when the patient receives multiple injections at the same visit
  • 95120: Allergen immunotherapy at prescribing physician's office including extract provision, single injection; replaces the 95165 plus 95115 combination when both are performed at the prescribing office
  • 95125: Same as 95120 but two or more injections at the prescribing physician's office
  • 95144: Antigen supervision and provision for single-dose vials; billed per vial; use when the prescribing format is single-dose rather than multi-dose
  • 95145: Antigen supervision and provision for a single stinging insect venom; per prescription; use for Hymenoptera venom immunotherapy
  • 95170: Antigen supervision and provision; whole-body extract of biting insect or other arthropod; per dose; parallel structure to 95165 for biting insect extracts
  • 95180: Rapid desensitization procedure; billed per hour; distinct protocol from standard subcutaneous immunotherapy antigen preparation

Sources

  1. CMS NCCI MUE Tables — Quarterly 2026, CMS. Medically Unlikely Edits; 95165 MUE = 30/day confirmed.
  2. CMS NCCI Policy Manual — 2025, CMS. Allergen immunotherapy bundling and unbundling rules, Chapter 11.
  3. CMS Physician Fee Schedule RVU Files — CY 2025/2026, CMS. Global days, PC/TC indicator, APC status, and RVUs for 95165.
  4. CMS Medicare Coverage Database — Current, CMS. WPS LCD L36728 (Allergy Testing and Immunotherapy); medical necessity criteria and documentation requirements.
  5. CMS Medicare Benefit Policy Manual — Current, CMS. Chapter 15 coverage of allergy services under Part B.
  6. AMA CPT Codebook, Allergy/Immunology Subsection — 2026, AMA. Official code descriptions, parenthetical notes, and coding guidelines for CPT 95115 through 95199.

Related Codes

Official Description

Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy; single or multiple antigens (specify number of doses)

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 95165 refers to the professional services involved in the supervision of the preparation and provision of antigens for allergen immunotherapy. This procedure is typically performed by an allergist or another qualified supplier who is responsible for preparing or overseeing the preparation of multiple dose vials containing specific antigens. These antigens are formulated based on the results obtained from allergy testing services, which are reported separately. The primary goal of this procedure is to create a correct dosage of the allergen that will be administered to the patient over a series of injections. Each multiple dose vial is designed to provide the appropriate formulation for a specified number of injections, ensuring that the patient receives the correct amount of allergen for effective immunotherapy. When reporting this service, the physician uses code 95165 for each multiple dose vial prepared for a single or multiple antigens, while code 95170 is used for whole-body extracts from biting insects or other arthropods. It is important to note that the allergist typically administers the first dose of the immunotherapy and monitors the patient for any adverse reactions. Subsequent doses are then administered by another physician using the multiple dose vials provided to the patient.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The procedure associated with CPT® Code 95165 is indicated for patients who require allergen immunotherapy based on the results of allergy testing. This therapy is typically recommended for individuals who have been diagnosed with specific allergies that can be effectively treated through the administration of antigens. The following conditions may warrant the use of this procedure:

  • Allergic Rhinitis Patients suffering from allergic rhinitis may benefit from allergen immunotherapy to reduce symptoms associated with pollen, dust mites, mold, or pet dander.
  • Allergic Asthma Individuals with allergic asthma may require immunotherapy to help manage their symptoms and improve overall respiratory function.
  • Insect Sting Allergies Patients who have experienced severe allergic reactions to insect stings may be candidates for immunotherapy to reduce the risk of future anaphylactic reactions.
  • Allergic Conjunctivitis Those with allergic conjunctivitis may also be treated with allergen immunotherapy to alleviate eye-related symptoms.

2. Procedure

The procedure for CPT® Code 95165 involves several key steps that ensure the safe and effective preparation of antigens for allergen immunotherapy. Each step is crucial for the successful formulation and administration of the treatment.

  • Step 1: Allergy Testing Initially, the patient undergoes allergy testing to identify specific allergens that trigger their symptoms. This testing is essential for determining the appropriate antigens to be included in the immunotherapy.
  • Step 2: Preparation of Antigens Based on the results of the allergy testing, the allergist or qualified supplier prepares the antigens. This involves formulating the correct dosage of the allergen, which is then placed into multiple dose vials. Each vial is designed to contain a specific number of doses for administration.
  • Step 3: Supervision of Preparation The allergist supervises the entire preparation process to ensure that the antigens are correctly formulated and that all safety protocols are followed. This supervision is a critical component of the service provided under CPT® Code 95165.
  • Step 4: Administration of the First Dose The allergist typically administers the first dose of the immunotherapy to the patient. This initial administration is closely monitored for any adverse effects, ensuring the patient's safety during the treatment.
  • Step 5: Subsequent Doses After the first dose, the patient is provided with the multiple dose vials containing the antigens. The patient then takes these vials to another physician, who is responsible for administering the remaining doses as per the treatment plan.

3. Post-Procedure

Post-procedure care following the administration of allergen immunotherapy is essential for monitoring the patient's response to the treatment. After the first dose is administered, the allergist observes the patient for any immediate adverse reactions, which may include symptoms such as swelling, itching, or difficulty breathing. It is crucial for the patient to be informed about potential side effects and to have a plan in place for managing any reactions that may occur. The patient should also be advised on the schedule for subsequent doses and the importance of adhering to the treatment regimen. Regular follow-up appointments may be necessary to assess the effectiveness of the immunotherapy and to make any adjustments to the treatment plan as needed.

Short Descr ANTIGEN THERAPY SERVICES
Medium Descr PREPJ& ALLERGEN IMMUNOTHERAPY 1/MLT ANTIGEN
Long Descr Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy; single or multiple antigens (specify number of doses)
Status Code Active Code
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 0 - Physician Service Code
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 0 - Payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator STV-Packaged Codes
Type of Service (TOS) 1 - Medical Care
Berenson-Eggers TOS (BETOS) M5D - Specialist - other
MUE 30
CCS Clinical Classification 228 - Prophylactic vaccinations and inoculations
76 Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
GY Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
GA Waiver of liability statement issued as required by payer policy, individual case
AQ Physician providing a service in an unlisted health professional shortage area (hpsa)
XU Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service
Q6 Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area
XE Separate encounter, a service that is distinct because it occurred during a separate encounter
CR Catastrophe/disaster related
GW Service not related to the hospice patient's terminal condition
SA Nurse practitioner rendering service in collaboration with a physician
25 Significant, separately identifiable evaluation and management service by the same physician or other qualified health care professional on the same day of the procedure or other service: it may be necessary to indicate that on the day a procedure or service identified by a cpt code was performed, the patient's condition required a significant, separately identifiable e/m service above and beyond the other service provided or beyond the usual preoperative and postoperative care associated with the procedure that was performed. a significant, separately identifiable e/m service is defined or substantiated by documentation that satisfies the relevant criteria for the respective e/m service to be reported (see evaluation and management services guidelines for instructions on determining level of e/m service). the e/m service may be prompted by the symptom or condition for which the procedure and/or service was provided. as such, different diagnoses are not required for reporting of the e/m services on the same date. this circumstance may be reported by adding modifier 25 to the appropriate level of e/m service. note: this modifier is not used to report an e/m service that resulted in a decision to perform surgery. see modifier 57 for significant, separately identifiable non-e/m services, see modifier 59.
XS Separate structure, a service that is distinct because it was performed on a separate organ/structure
79 Unrelated procedure or service by the same physician or other qualified health care professional during the postoperative period: the individual may need to indicate that the performance of a procedure or service during the postoperative period was unrelated to the original procedure. this circumstance may be reported by using modifier 79. (for repeat procedures on the same day, see modifier 76.)
GV Attending physician not employed or paid under arrangement by the patient's hospice provider
GZ Item or service expected to be denied as not reasonable and necessary
CC Procedure code change (use 'cc' when the procedure code submitted was changed either for administrative reasons or because an incorrect code was filed)
AG Primary physician
GC This service has been performed in part by a resident under the direction of a teaching physician
95 Synchronous telemedicine service rendered via a real-time interactive audio and video telecommunications system: synchronous telemedicine service is defined as a real-time interaction between a physician or other qualified health care professional and a patient who is located at a distant site from the physician or other qualified health care professional. the totality of the communication of information exchanged between the physician or other qualified health care professional and the patient during the course of the synchronous telemedicine service must be of an amount and nature that would be sufficient to meet the key components and/or requirements of the same service when rendered via a face-to-face interaction. modifier 95 may only be appended to the services listed in appendix p. appendix p is the list of cpt codes for services that are typically performed face-to-face, but may be rendered via a real-time (synchronous) interactive audio and video telecommunications system.
Q5 Service furnished under a reciprocal billing arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area
27 Multiple outpatient hospital e/m encounters on the same date: for hospital outpatient reporting purposes, utilization of hospital resources related to separate and distinct e/m encounters performed in multiple outpatient hospital settings on the same date may be reported by adding modifier 27 to each appropriate level outpatient and/or emergency department e/m code(s). this modifier provides a means of reporting circumstances involving evaluation and management services provided by physician(s) in more than one (multiple) outpatient hospital setting(s) (eg, hospital emergency department, clinic). note: this modifier is not to be used for physician reporting of multiple e/m services performed by the same physician on the same date. for physician reporting of all outpatient evaluation and management services provided by the same physician on the same date and performed in multiple outpatient setting(s) (eg, hospital emergency department, clinic), see evaluation and management, emergency department, or preventive medicine services codes.
JZ Zero drug amount discarded/not administered to any patient
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
L1 Provider attestation that the hospital laboratory test(s) is not packaged under the hospital opps
Date
Action
Notes
2011-01-01 Changed Medium description changed.
2002-01-01 Changed Code description changed.
1994-01-01 Added First appearance in code book in 1994.
Code
Description
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"